1 Human Hyperimmune Globulins Market Overview 1.1 Human Hyperimmune Globulins Product Scope 1.2 Human Hyperimmune Globulins Segment by Type 1.2.1 Global Human Hyperimmune Globulins Sales by Type (2016 & 2021 & 2027) 1.2.2 Hepatitis B Immunoglobulins 1.2.3 Rabies Immunoglobulins 1.2.4 Tetanus Immunoglobulins 1.2.5 Others 1.3 Human Hyperimmune Globulins Segment by Application 1.3.1 Global Human Hyperimmune Globulins Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Government Institutions 1.3.3 Private Sector 1.3.4 Others 1.4 Human Hyperimmune Globulins Market Estimates and Forecasts (2016-2027) 1.4.1 Global Human Hyperimmune Globulins Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Human Hyperimmune Globulins Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Human Hyperimmune Globulins Price Trends (2016-2027) 2 Human Hyperimmune Globulins Estimates and Forecasts by Region 2.1 Global Human Hyperimmune Globulins Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Human Hyperimmune Globulins Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Human Hyperimmune Globulins Sales Market Share by Region (2016-2021) 2.2.2 Global Human Hyperimmune Globulins Revenue Market Share by Region (2016-2021) 2.3 Global Human Hyperimmune Globulins Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Human Hyperimmune Globulins Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Human Hyperimmune Globulins Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Human Hyperimmune Globulins Estimates and Projections (2016-2027) 2.4.2 Europe Human Hyperimmune Globulins Estimates and Projections (2016-2027) 2.4.3 China Human Hyperimmune Globulins Estimates and Projections (2016-2027) 2.4.4 Japan Human Hyperimmune Globulins Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Human Hyperimmune Globulins Estimates and Projections (2016-2027) 2.4.6 India Human Hyperimmune Globulins Estimates and Projections (2016-2027) 3 Global Human Hyperimmune Globulins Competition Landscape by Players 3.1 Global Top Human Hyperimmune Globulins Players by Sales (2016-2021) 3.2 Global Top Human Hyperimmune Globulins Players by Revenue (2016-2021) 3.3 Global Human Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Hyperimmune Globulins as of 2020) 3.4 Global Human Hyperimmune Globulins Average Price by Company (2016-2021) 3.5 Manufacturers Human Hyperimmune Globulins Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Human Hyperimmune Globulins Market Size by Type 4.1 Global Human Hyperimmune Globulins Historic Market Review by Type (2016-2021) 4.1.1 Global Human Hyperimmune Globulins Sales Market Share by Type (2016-2021) 4.1.2 Global Human Hyperimmune Globulins Revenue Market Share by Type (2016-2021) 4.1.3 Global Human Hyperimmune Globulins Price by Type (2016-2021) 4.2 Global Human Hyperimmune Globulins Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Human Hyperimmune Globulins Sales Forecast by Type (2022-2027) 4.2.2 Global Human Hyperimmune Globulins Revenue Forecast by Type (2022-2027) 4.2.3 Global Human Hyperimmune Globulins Price Forecast by Type (2022-2027) 5 Global Human Hyperimmune Globulins Market Size by Application 5.1 Global Human Hyperimmune Globulins Historic Market Review by Application (2016-2021) 5.1.1 Global Human Hyperimmune Globulins Sales Market Share by Application (2016-2021) 5.1.2 Global Human Hyperimmune Globulins Revenue Market Share by Application (2016-2021) 5.1.3 Global Human Hyperimmune Globulins Price by Application (2016-2021) 5.2 Global Human Hyperimmune Globulins Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Human Hyperimmune Globulins Sales Forecast by Application (2022-2027) 5.2.2 Global Human Hyperimmune Globulins Revenue Forecast by Application (2022-2027) 5.2.3 Global Human Hyperimmune Globulins Price Forecast by Application (2022-2027) 6 North America Human Hyperimmune Globulins Market Facts & Figures 6.1 North America Human Hyperimmune Globulins Sales by Company 6.1.1 North America Human Hyperimmune Globulins Sales by Company (2016-2021) 6.1.2 North America Human Hyperimmune Globulins Revenue by Company (2016-2021) 6.2 North America Human Hyperimmune Globulins Sales Breakdown by Type 6.2.1 North America Human Hyperimmune Globulins Sales Breakdown by Type (2016-2021) 6.2.2 North America Human Hyperimmune Globulins Sales Breakdown by Type (2022-2027) 6.3 North America Human Hyperimmune Globulins Sales Breakdown by Application 6.3.1 North America Human Hyperimmune Globulins Sales Breakdown by Application (2016-2021) 6.3.2 North America Human Hyperimmune Globulins Sales Breakdown by Application (2022-2027) 7 Europe Human Hyperimmune Globulins Market Facts & Figures 7.1 Europe Human Hyperimmune Globulins Sales by Company 7.1.1 Europe Human Hyperimmune Globulins Sales by Company (2016-2021) 7.1.2 Europe Human Hyperimmune Globulins Revenue by Company (2016-2021) 7.2 Europe Human Hyperimmune Globulins Sales Breakdown by Type 7.2.1 Europe Human Hyperimmune Globulins Sales Breakdown by Type (2016-2021) 7.2.2 Europe Human Hyperimmune Globulins Sales Breakdown by Type (2022-2027) 7.3 Europe Human Hyperimmune Globulins Sales Breakdown by Application 7.3.1 Europe 147 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 147 Sales Breakdown by Application (2022-2027) 8 China Human Hyperimmune Globulins Market Facts & Figures 8.1 China Human Hyperimmune Globulins Sales by Company 8.1.1 China Human Hyperimmune Globulins Sales by Company (2016-2021) 8.1.2 China Human Hyperimmune Globulins Revenue by Company (2016-2021) 8.2 China Human Hyperimmune Globulins Sales Breakdown by Type 8.2.1 China Human Hyperimmune Globulins Sales Breakdown by Type (2016-2021) 8.2.2 China Human Hyperimmune Globulins Sales Breakdown by Type (2022-2027) 8.3 China Human Hyperimmune Globulins Sales Breakdown by Application 8.3.1 China 314 Sales Breakdown by Application (2016-2021) 8.3.2 China 314 Sales Breakdown by Application (2022-2027) 9 Japan Human Hyperimmune Globulins Market Facts & Figures 9.1 Japan Human Hyperimmune Globulins Sales by Company 9.1.1 Japan Human Hyperimmune Globulins Sales by Company (2016-2021) 9.1.2 Japan Human Hyperimmune Globulins Revenue by Company (2016-2021) 9.2 Japan Human Hyperimmune Globulins Sales Breakdown by Type 9.2.1 Japan Human Hyperimmune Globulins Sales Breakdown by Type (2016-2021) 9.2.2 Japan Human Hyperimmune Globulins Sales Breakdown by Type (2022-2027) 9.3 Japan Human Hyperimmune Globulins Sales Breakdown by Application 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Human Hyperimmune Globulins Market Facts & Figures 10.1 Southeast Asia Human Hyperimmune Globulins Sales by Company 10.1.1 Southeast Asia Human Hyperimmune Globulins Sales by Company (2016-2021) 10.1.2 Southeast Asia Human Hyperimmune Globulins Revenue by Company (2016-2021) 10.2 Southeast Asia Human Hyperimmune Globulins Sales Breakdown by Type 10.2.1 Southeast Asia Human Hyperimmune Globulins Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Human Hyperimmune Globulins Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Human Hyperimmune Globulins Sales Breakdown by Application 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027) 11 India Human Hyperimmune Globulins Market Facts & Figures 11.1 India Human Hyperimmune Globulins Sales by Company 11.1.1 India Human Hyperimmune Globulins Sales by Company (2016-2021) 11.1.2 India Human Hyperimmune Globulins Revenue by Company (2016-2021) 11.2 India Human Hyperimmune Globulins Sales Breakdown by Type 11.2.1 India Human Hyperimmune Globulins Sales Breakdown by Type (2016-2021) 11.2.2 India Human Hyperimmune Globulins Sales Breakdown by Type (2022-2027) 11.3 India Human Hyperimmune Globulins Sales Breakdown by Application 11.3.1 India Human Hyperimmune Globulins Sales Breakdown by Application (2016-2021) 11.3.2 India Human Hyperimmune Globulins Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Human Hyperimmune Globulins Business 12.1 CSL Behring 12.1.1 CSL Behring Corporation Information 12.1.2 CSL Behring Business Overview 12.1.3 CSL Behring Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021) 12.1.4 CSL Behring Human Hyperimmune Globulins Products Offered 12.1.5 CSL Behring Recent Development 12.2 Grifols 12.2.1 Grifols Corporation Information 12.2.2 Grifols Business Overview 12.2.3 Grifols Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Grifols Human Hyperimmune Globulins Products Offered 12.2.5 Grifols Recent Development 12.3 Biotest 12.3.1 Biotest Corporation Information 12.3.2 Biotest Business Overview 12.3.3 Biotest Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Biotest Human Hyperimmune Globulins Products Offered 12.3.5 Biotest Recent Development 12.4 Kedrion 12.4.1 Kedrion Corporation Information 12.4.2 Kedrion Business Overview 12.4.3 Kedrion Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Kedrion Human Hyperimmune Globulins Products Offered 12.4.5 Kedrion Recent Development 12.5 CBPO 12.5.1 CBPO Corporation Information 12.5.2 CBPO Business Overview 12.5.3 CBPO Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021) 12.5.4 CBPO Human Hyperimmune Globulins Products Offered 12.5.5 CBPO Recent Development 12.6 Emergent (Cangene) 12.6.1 Emergent (Cangene) Corporation Information 12.6.2 Emergent (Cangene) Business Overview 12.6.3 Emergent (Cangene) Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Emergent (Cangene) Human Hyperimmune Globulins Products Offered 12.6.5 Emergent (Cangene) Recent Development 12.7 Kamada 12.7.1 Kamada Corporation Information 12.7.2 Kamada Business Overview 12.7.3 Kamada Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Kamada Human Hyperimmune Globulins Products Offered 12.7.5 Kamada Recent Development 12.8 CNBG 12.8.1 CNBG Corporation Information 12.8.2 CNBG Business Overview 12.8.3 CNBG Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021) 12.8.4 CNBG Human Hyperimmune Globulins Products Offered 12.8.5 CNBG Recent Development 12.9 Hualan Bio 12.9.1 Hualan Bio Corporation Information 12.9.2 Hualan Bio Business Overview 12.9.3 Hualan Bio Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Hualan Bio Human Hyperimmune Globulins Products Offered 12.9.5 Hualan Bio Recent Development 12.10 Shanghai RAAS 12.10.1 Shanghai RAAS Corporation Information 12.10.2 Shanghai RAAS Business Overview 12.10.3 Shanghai RAAS Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Shanghai RAAS Human Hyperimmune Globulins Products Offered 12.10.5 Shanghai RAAS Recent Development 12.11 Sichuan Yuanda Shuyang 12.11.1 Sichuan Yuanda Shuyang Corporation Information 12.11.2 Sichuan Yuanda Shuyang Business Overview 12.11.3 Sichuan Yuanda Shuyang Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Sichuan Yuanda Shuyang Human Hyperimmune Globulins Products Offered 12.11.5 Sichuan Yuanda Shuyang Recent Development 12.12 ADMA Biologics 12.12.1 ADMA Biologics Corporation Information 12.12.2 ADMA Biologics Business Overview 12.12.3 ADMA Biologics Human Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021) 12.12.4 ADMA Biologics Human Hyperimmune Globulins Products Offered 12.12.5 ADMA Biologics Recent Development 13 Human Hyperimmune Globulins Manufacturing Cost Analysis 13.1 Human Hyperimmune Globulins Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Human Hyperimmune Globulins 13.4 Human Hyperimmune Globulins Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Human Hyperimmune Globulins Distributors List 14.3 Human Hyperimmune Globulins Customers 15 Market Dynamics 15.1 Human Hyperimmune Globulins Market Trends 15.2 Human Hyperimmune Globulins Drivers 15.3 Human Hyperimmune Globulins Market Challenges 15.4 Human Hyperimmune Globulins Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Human Hyperimmune Globulins Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Human Hyperimmune Globulins Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Human Hyperimmune Globulins Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Human Hyperimmune Globulins Sales (K Units) by Region (2016-2021) Table 5. Global Human Hyperimmune Globulins Sales Market Share by Region (2016-2021) Table 6. Global Human Hyperimmune Globulins Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Human Hyperimmune Globulins Revenue Share by Region (2016-2021) Table 8. Global Human Hyperimmune Globulins Sales (K Units) Forecast by Region (2022-2027) Table 9. Global Human Hyperimmune Globulins Sales Market Share Forecast by Region (2022-2027) Table 10. Global Human Hyperimmune Globulins Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Human Hyperimmune Globulins Revenue Share Forecast by Region (2022-2027) Table 12. Global Human Hyperimmune Globulins Sales (K Units) of Key Companies (2016-2021) Table 13. Global Human Hyperimmune Globulins Sales Share by Company (2016-2021) Table 14. Global Human Hyperimmune Globulins Revenue (US$ Million) by Company (2016-2021) Table 15. Global Human Hyperimmune Globulins Revenue Share by Company (2016-2021) Table 16. Global Human Hyperimmune Globulins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Hyperimmune Globulins as of 2020) Table 17. Global Human Hyperimmune Globulins Average Price (US$/Unit) of Key Company (2016-2021) Table 18. Manufacturers Human Hyperimmune Globulins Manufacturing Sites and Area Served Table 19. Manufacturers Human Hyperimmune Globulins Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Human Hyperimmune Globulins Sales (K Units) by Type (2016-2021) Table 22. Global Human Hyperimmune Globulins Sales Share by Type (2016-2021) Table 23. Global Human Hyperimmune Globulins Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Human Hyperimmune Globulins Price (US$/Unit) by Type (2016-2021) Table 25. Global Human Hyperimmune Globulins Sales Share by Type (2022-2027) Table 26. Global Human Hyperimmune Globulins Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Human Hyperimmune Globulins Revenue Share by Type (2022-2027) Table 28. Global Human Hyperimmune Globulins Price (US$/Unit) by Type (2022-2027) Table 29. Global Human Hyperimmune Globulins Sales (K Units) by Application (2016-2021) Table 30. Global Human Hyperimmune Globulins Sales Share by Application (2016-2021) Table 31. Global Human Hyperimmune Globulins Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Human Hyperimmune Globulins Price (US$/Unit) by Application (2016-2021) Table 33. Global Human Hyperimmune Globulins Sales (K Units) by Application (2022-2027) Table 34. Global Human Hyperimmune Globulins Sales Share by Application (2022-2027) Table 35. Global Human Hyperimmune Globulins Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Human Hyperimmune Globulins Revenue Share by Application (2022-2027) Table 37. Global Human Hyperimmune Globulins Price (US$/Unit) by Application (2022-2027) Table 38. North America Human Hyperimmune Globulins Sales (K Units) by Company (2016-2021) Table 39. North America Human Hyperimmune Globulins Sales Market Share by Company (2016-2021) Table 40. North America Human Hyperimmune Globulins Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Human Hyperimmune Globulins Revenue Market Share by Company (2016-2021) Table 42. North America Human Hyperimmune Globulins Sales by Type (2016-2021) & (K Units) Table 43. North America Human Hyperimmune Globulins Sales Market Share by Type (2016-2021) Table 44. North America Human Hyperimmune Globulins Sales by Type (2022-2027) & (K Units) Table 45. North America Human Hyperimmune Globulins Sales Market Share by Type (2022-2027) Table 46. North America Human Hyperimmune Globulins Sales by Application (2016-2021) & (K Units) Table 47. North America Human Hyperimmune Globulins Sales Market Share by Application (2016-2021) Table 48. North America Human Hyperimmune Globulins Sales by Application (2022-2027) & (K Units) Table 49. North America Human Hyperimmune Globulins Sales Market Share by Application (2022-2027) Table 50. Europe Human Hyperimmune Globulins Sales (K Units) by Company (2016-2021) Table 51. Europe Human Hyperimmune Globulins Sales Market Share by Company (2016-2021) Table 52. Europe Human Hyperimmune Globulins Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Human Hyperimmune Globulins Revenue Market Share by Company (2016-2021) Table 54. Europe Human Hyperimmune Globulins Sales by Type (2016-2021) & (K Units) Table 55. Europe Human Hyperimmune Globulins Sales Market Share by Type (2016-2021) Table 56. Europe Human Hyperimmune Globulins Sales by Type (2022-2027) & (K Units) Table 57. Europe Human Hyperimmune Globulins Sales Market Share by Type (2022-2027) Table 58. Europe Human Hyperimmune Globulins Sales by Application (2016-2021) & (K Units) Table 59. Europe Human Hyperimmune Globulins Sales Market Share by Application (2016-2021) Table 60. Europe Human Hyperimmune Globulins Sales by Application (2022-2027) & (K Units) Table 61. Europe Human Hyperimmune Globulins Sales Market Share by Application (2022-2027) Table 62. China Human Hyperimmune Globulins Sales (K Units) by Company (2016-2021) Table 63. China Human Hyperimmune Globulins Sales Market Share by Company (2016-2021) Table 64. China Human Hyperimmune Globulins Revenue by Company (2016-2021) & (US$ Million) Table 65. China Human Hyperimmune Globulins Revenue Market Share by Company (2016-2021) Table 66. China Human Hyperimmune Globulins Sales by Type (2016-2021) & (K Units) Table 67. China Human Hyperimmune Globulins Sales Market Share by Type (2016-2021) Table 68. China Human Hyperimmune Globulins Sales by Type (2022-2027) & (K Units) Table 69. China Human Hyperimmune Globulins Sales Market Share by Type (2022-2027) Table 70. China Human Hyperimmune Globulins Sales by Application (2016-2021) & (K Units) Table 71. China Human Hyperimmune Globulins Sales Market Share by Application (2016-2021) Table 72. China Human Hyperimmune Globulins Sales by Application (2022-2027) & (K Units) Table 73. China Human Hyperimmune Globulins Sales Market Share by Application (2022-2027) Table 74. Japan Human Hyperimmune Globulins Sales (K Units) by Company (2016-2021) Table 75. Japan Human Hyperimmune Globulins Sales Market Share by Company (2016-2021) Table 76. Japan Human Hyperimmune Globulins Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Human Hyperimmune Globulins Revenue Market Share by Company (2016-2021) Table 78. Japan Human Hyperimmune Globulins Sales by Type (2016-2021) & (K Units) Table 79. Japan Human Hyperimmune Globulins Sales Market Share by Type (2016-2021) Table 80. Japan Human Hyperimmune Globulins Sales by Type (2022-2027) & (K Units) Table 81. Japan Human Hyperimmune Globulins Sales Market Share by Type (2022-2027) Table 82. Japan Human Hyperimmune Globulins Sales by Application (2016-2021) & (K Units) Table 83. Japan Human Hyperimmune Globulins Sales Market Share by Application (2016-2021) Table 84. Japan Human Hyperimmune Globulins Sales by Application (2022-2027) & (K Units) Table 85. Japan Human Hyperimmune Globulins Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Human Hyperimmune Globulins Sales (K Units) by Company (2016-2021) Table 87. Southeast Asia Human Hyperimmune Globulins Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Human Hyperimmune Globulins Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Human Hyperimmune Globulins Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Human Hyperimmune Globulins Sales by Type (2016-2021) & (K Units) Table 91. Southeast Asia Human Hyperimmune Globulins Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Human Hyperimmune Globulins Sales by Type (2022-2027) & (K Units) Table 93. Southeast Asia Human Hyperimmune Globulins Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Human Hyperimmune Globulins Sales by Application (2016-2021) & (K Units) Table 95. Southeast Asia Human Hyperimmune Globulins Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Human Hyperimmune Globulins Sales by Application (2022-2027) & (K Units) Table 97. Southeast Asia Human Hyperimmune Globulins Sales Market Share by Application (2022-2027) Table 98. India Human Hyperimmune Globulins Sales (K Units) by Company (2016-2021) Table 99. India Human Hyperimmune Globulins Sales Market Share by Company (2016-2021) Table 100. India Human Hyperimmune Globulins Revenue by Company (2016-2021) & (US$ Million) Table 101. India Human Hyperimmune Globulins Revenue Market Share by Company (2016-2021) Table 102. India Human Hyperimmune Globulins Sales by Type (2016-2021) & (K Units) Table 103. India Human Hyperimmune Globulins Sales Market Share by Type (2016-2021) Table 104. India Human Hyperimmune Globulins Sales by Type (2022-2027) & (K Units) Table 105. India Human Hyperimmune Globulins Sales Market Share by Type (2022-2027) Table 106. India Human Hyperimmune Globulins Sales by Application (2016-2021) & (K Units) Table 107. India Human Hyperimmune Globulins Sales Market Share by Application (2016-2021) Table 108. India Human Hyperimmune Globulins Sales by Application (2022-2027) & (K Units) Table 109. India Human Hyperimmune Globulins Sales Market Share by Application (2022-2027) Table 110. CSL Behring Corporation Information Table 111. CSL Behring Description and Business Overview Table 112. CSL Behring Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 113. CSL Behring Human Hyperimmune Globulins Product Table 114. CSL Behring Recent Development Table 115. Grifols Corporation Information Table 116. Grifols Description and Business Overview Table 117. Grifols Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 118. Grifols Human Hyperimmune Globulins Product Table 119. Grifols Recent Development Table 120. Biotest Corporation Information Table 121. Biotest Description and Business Overview Table 122. Biotest Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 123. Biotest Human Hyperimmune Globulins Product Table 124. Biotest Recent Development Table 125. Kedrion Corporation Information Table 126. Kedrion Description and Business Overview Table 127. Kedrion Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 128. Kedrion Human Hyperimmune Globulins Product Table 129. Kedrion Recent Development Table 130. CBPO Corporation Information Table 131. CBPO Description and Business Overview Table 132. CBPO Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 133. CBPO Human Hyperimmune Globulins Product Table 134. CBPO Recent Development Table 135. Emergent (Cangene) Corporation Information Table 136. Emergent (Cangene) Description and Business Overview Table 137. Emergent (Cangene) Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 138. Emergent (Cangene) Human Hyperimmune Globulins Product Table 139. Emergent (Cangene) Recent Development Table 140. Kamada Corporation Information Table 141. Kamada Description and Business Overview Table 142. Kamada Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 143. Kamada Human Hyperimmune Globulins Product Table 144. Kamada Recent Development Table 145. CNBG Corporation Information Table 146. CNBG Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 147. CNBG Description and Business Overview Table 148. CNBG Human Hyperimmune Globulins Product Table 149. CNBG Recent Development Table 150. Hualan Bio Corporation Information Table 151. Hualan Bio Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 152. Hualan Bio Description and Business Overview Table 153. Hualan Bio Human Hyperimmune Globulins Product Table 154. Hualan Bio Recent Development Table 155. Shanghai RAAS Corporation Information Table 156. Shanghai RAAS Description and Business Overview Table 157. Shanghai RAAS Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 158. Shanghai RAAS Human Hyperimmune Globulins Product Table 159. Shanghai RAAS Recent Development Table 160. Sichuan Yuanda Shuyang Corporation Information Table 161. Sichuan Yuanda Shuyang Description and Business Overview Table 162. Sichuan Yuanda Shuyang Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 163. Sichuan Yuanda Shuyang Human Hyperimmune Globulins Product Table 164. Sichuan Yuanda Shuyang Recent Development Table 165. ADMA Biologics Corporation Information Table 166. ADMA Biologics Description and Business Overview Table 167. ADMA Biologics Human Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021) Table 168. ADMA Biologics Human Hyperimmune Globulins Product Table 169. ADMA Biologics Recent Development Table 170. Production Base and Market Concentration Rate of Raw Material Table 171. Key Suppliers of Raw Materials Table 172. Human Hyperimmune Globulins Distributors List Table 173. Human Hyperimmune Globulins Customers List Table 174. Human Hyperimmune Globulins Market Trends Table 175. Human Hyperimmune Globulins Market Drivers Table 176. Human Hyperimmune Globulins Market Challenges Table 177. Human Hyperimmune Globulins Market Restraints Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Human Hyperimmune Globulins Product Picture Figure 2. Global Human Hyperimmune Globulins Sales Market Share by Type in 2021 & 2027 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Human Hyperimmune Globulins Sales Market Share by Application in 2021 & 2027 Figure 6. Government Institutions Examples Figure 7. Private Sector Examples Figure 8. Others Examples Figure 9. Global Human Hyperimmune Globulins Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Human Hyperimmune Globulins Sales Growth Rate (2016-2027) & (US$ Million) Figure 11. Global Human Hyperimmune Globulins Sales (K Units) Growth Rate (2016-2027) Figure 12. Global Human Hyperimmune Globulins Price Trends Growth Rate (2016-2027) (US$/Unit) Figure 13. Global Human Hyperimmune Globulins Revenue Market Share by Region: 2016 VS 2021 Figure 14. Global Human Hyperimmune Globulins Revenue Market Share by Region: 2021 VS 2027 Figure 15. North America Human Hyperimmune Globulins Revenue (Million USD) Growth Rate (2016-2027) Figure 16. North America Human Hyperimmune Globulins Sales (K Units) Growth Rate (2016-2027) Figure 17. Europe Human Hyperimmune Globulins Revenue (Million USD) Growth Rate (2016-2027) Figure 18. Europe Human Hyperimmune Globulins Sales (Million USD) Growth Rate (2016-2027) Figure 19. China Human Hyperimmune Globulins Revenue (Million USD) Growth Rate (2016-2027) Figure 20. China Human Hyperimmune Globulins Sales (Million USD) and Growth Rate (2016-2027) Figure 21. Japan Human Hyperimmune Globulins Revenue (Million USD) Growth Rate (2016-2027) Figure 22. Japan Human Hyperimmune Globulins Sales (Million USD) Growth Rate (2016-2027) Figure 23. Southeast Asia Human Hyperimmune Globulins Revenue (Million USD) Growth Rate (2016-2027) Figure 24. Southeast Asia Human Hyperimmune Globulins Sales (Million USD) Growth Rate (2016-2027) Figure 25. India Human Hyperimmune Globulins Revenue (Million USD) Growth Rate (2016-2027) Figure 26. India Human Hyperimmune Globulins Sales (Million USD) Growth Rate (2016-2027) Figure 27. Global 5 Largest Human Hyperimmune Globulins Players Market Share by Revenue in Human Hyperimmune Globulins: 2016 & 2020 Figure 28. Human Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 29. Global Human Hyperimmune Globulins Revenue Share by Type (2016-2021) Figure 30. Global Human Hyperimmune Globulins Revenue Growth Rate by Type in 2016 & 2020 Figure 31. Global Human Hyperimmune Globulins Revenue Share by Application (2016-2021) Figure 32. Global Human Hyperimmune Globulins Revenue Growth Rate by Application in 2016 & 2020 Figure 33. North America Human Hyperimmune Globulins Sales Market Share by Type in 2020 Figure 34. North America Human Hyperimmune Globulins Sales Market Share by Application in 2020 Figure 35. Europe Human Hyperimmune Globulins Sales Market Share by Type in 2020 Figure 36. Europe Human Hyperimmune Globulins Sales Market Share by Application in 2020 Figure 37. China Human Hyperimmune Globulins Sales Market Share by Type in 2020 Figure 38. China Human Hyperimmune Globulins Sales Market Share by Application in 2020 Figure 39. Japan Human Hyperimmune Globulins Sales Market Share by Type in 2020 Figure 40. Japan Human Hyperimmune Globulins Sales Market Share by Application in 2020 Figure 41. Southeast Asia Human Hyperimmune Globulins Sales Market Share by Type in 2020 Figure 42. Southeast Asia Human Hyperimmune Globulins Sales Market Share by Application in 2020 Figure 43. India Human Hyperimmune Globulins Sales Market Share by Type in 2020 Figure 44. India Human Hyperimmune Globulins Sales Market Share by Application in 2020 Figure 45. Key Raw Materials Price Trend Figure 46. Manufacturing Cost Structure of Human Hyperimmune Globulins Figure 47. Manufacturing Process Analysis of Human Hyperimmune Globulins Figure 48. Human Hyperimmune Globulins Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

CSL Behring Grifols Biotest Kedrion CBPO Emergent (Cangene) Kamada CNBG Hualan Bio Shanghai RAAS Sichuan Yuanda Shuyang ADMA Biologics